Green Thumb Industries GTBIF
OTC GTBIF
$7.62 +0.37 (+5.10%)
At close: Aug 19, 2026 · 3:59 PM UTC

Green Thumb Industries (GTBIF) Interest & Investment Income (2019 - 2026)

Green Thumb Industries' (GTBIF) quarterly Interest & Investment Income came in at $4.6 million in Q1 2026, up 116.82% YoY from $2.1 million in Q1 2025, and up 13.82% on a QoQ basis from $4.0 million in Q4 2025.

Green Thumb Industries (GTBIF) Interest & Investment Income (2019 - 2026) Analysis & Trends

Green Thumb Industries (GTBIF) has 8 years of Interest & Investment Income data on file, last reported at $4.6 million in Q1 2026.

  • Quarterly Interest & Investment Income rose 116.82% year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.9 million (up 52.38% YoY) and the FY2025 annual result came in at $11.4 million, up 25.38% from the prior year.
  • Interest & Investment Income advanced to $4.6 million in Q1 2026, from $4.0 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $4.6 million in Q1 2026 to a low of $624000.0 in Q2 2022.
  • A 5-year average of $2.1 million and a median of $1.9 million in 2025 frame the typical range for Interest & Investment Income.
  • Annual changes were most pronounced in 2022 — Interest & Investment Income soared 1700.0% — and 2025, when it retreated 17.46%.
  • Tracing GTBIF's Interest & Investment Income over 5 years: stood at $1.5 million in 2022, then gained by 27.24% to $1.9 million in 2023, then increased by 7.15% to $2.0 million in 2024, then surged by 103.01% to $4.0 million in 2025, then rose by 13.82% to $4.6 million in 2026.
  • The last three Interest & Investment Income figures came in at $4.6 million (Q1 2026), $4.0 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Haleon 43.92 Bn 42.96 Bn - -
2 Teva Pharmaceutical Industries 43.19 Bn 39.53 Bn 2.15 Bn -
3 Zoetis 31.74 Bn 30.06 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.67 Bn 22.87 Bn 5.10 Bn 154.39 Mn
5 United Therapeutics 22.22 Bn 19.56 Bn 683.80 Mn 31.50 Mn
6 Viatris 18.71 Bn 17.83 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.55 Bn 15.16 Bn 935.80 Mn 12.40 Mn
8 Elanco Animal Health 11.80 Bn 11.27 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn - -
10 Green Thumb Industries 1.66 Bn 1.37 Bn 137.87 Mn 4.30 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 4.30 Mn
Mar 31, 2026 4.60 Mn
Dec 31, 2025 4.04 Mn
Sep 30, 2025 3.30 Mn
Jun 30, 2025 1.91 Mn
Mar 31, 2025 2.12 Mn
Dec 31, 2024 1.99 Mn
Sep 30, 2024 2.67 Mn
Jun 30, 2024 2.31 Mn
Mar 31, 2024 2.10 Mn
Dec 31, 2023 1.86 Mn
Sep 30, 2023 1.58 Mn
Jun 30, 2023 1.53 Mn
Mar 31, 2023 1.73 Mn
Dec 31, 2022 1.46 Mn
Sep 30, 2022 1.09 Mn
Jun 30, 2022 624,000.00
Mar 31, 2022 900,000.00
Dec 31, 2021 758,000.00
Sep 30, 2021 328,000.00